Cargando…
Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort
BACKGROUND & AIMS: Immune checkpoint inhibitors (ICIs) have changed the landscape of cancer therapy. Liver toxicity occurs in up to 25% of patients treated with ICIs. The aim of our study was to describe the different clinical patterns of ICI-induced hepatitis and to assess their outcome. METHOD...
Autores principales: | Hountondji, Lina, Ferreira De Matos, Christophe, Lebossé, Fanny, Quantin, Xavier, Lesage, Candice, Palassin, Pascale, Rivet, Valérian, Faure, Stéphanie, Pageaux, Georges-Philippe, Assenat, Éric, Alric, Laurent, Zahhaf, Amel, Larrey, Dominique, Witkowski Durand Viel, Philine, Riviere, Benjamin, Janick, Selves, Dalle, Stéphane, Maria, Alexandre Thibault Jacques, Comont, Thibaut, Meunier, Lucy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149360/ https://www.ncbi.nlm.nih.gov/pubmed/37138674 http://dx.doi.org/10.1016/j.jhepr.2023.100719 |
Ejemplares similares
-
Plasma hPG(80) (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Dupuy, Marie, et al.
Publicado: (2022) -
KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
por: Bournet, Barbara, et al.
Publicado: (2016) -
Progression of AFP SCORE is a Preoperative Predictive Factor of Microvascular Invasion in Selected Patients Meeting Liver Transplantation Criteria for Hepatocellular Carcinoma
por: Herrero, Astrid, et al.
Publicado: (2022) -
Patient adherence issues in the treatment of hepatitis C
por: Larrey, Dominique, et al.
Publicado: (2014) -
Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation
por: Meunier, Lucy, et al.
Publicado: (2019)